Related Experiment Video
Updated: May 19, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Bcl-2: Live and let die
Eva Maria Putz1, Christian Schuster, Veronika Sexl
1Institute of Pharmacology and Toxicology; Department for Biomedical Sciences; Veterinary University of Vienna; Vienna, Austria.
Abstract:
Recent findings from our laboratory provide the first indication that overexpression of Bcl-2 in Eµ-myc transgenic cells enhances tumor immunosurveillance by inducing NKG2D ligands. Initial evidence suggests that this model is relevant to human patients. Thus, antitumor therapies that target Bcl-2 harbor the risk of reducing tumor immunogenicity.
Insights
Overexpressing Bcl-2 in cancer cells boosts immune surveillance by increasing NKG2D ligands. However, targeting Bcl-2 in therapies may decrease tumor immunogenicity, posing a risk.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Bcl-2 is a key regulator of apoptosis, often overexpressed in cancers.
- Tumor immunosurveillance is a critical mechanism by which the immune system eliminates cancer cells.
Purpose of the Study:
- To investigate the role of Bcl-2 in tumor immunosurveillance.
- To determine the effect of Bcl-2 overexpression on immune cell recognition of cancer cells.
Main Methods:
- Utilized Eµ-myc transgenic mouse models.
- Analyzed the expression of NKG2D ligands in cancer cells with altered Bcl-2 levels.
Main Results:
- Overexpression of Bcl-2 in Eµ-myc transgenic cells was found to enhance tumor immunosurveillance.
- This enhancement was mediated by the induction of NKG2D ligands.
- Preliminary data indicate relevance to human cancer patients.
Conclusions:
- Targeting Bcl-2 in antitumor therapies may inadvertently reduce tumor immunogenicity.
- This suggests a potential trade-off between direct anti-cancer effects and immune system engagement when targeting Bcl-2.
More Related Videos
09:24Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
09:58Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
Published on: January 7, 2019
Related Concept Videos
Binary Fission
Binary Fission
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
The Intrinsic Apoptotic Pathway
The DNA Helix
The DNA Helix